Status:
COMPLETED
Low Residue Diet During 3 Days vs 1 Day Prior Colonoscopy
Lead Sponsor:
Parc Taulí Hospital Universitari
Conditions:
Colonoscopy
Colon Adenoma
Eligibility:
All Genders
50-69 years
Phase:
NA
Brief Summary
Colonoscopy is the gold-standard for the evaluation of the colorectal mucosa. Colonoscopy quality indicators are the adenoma detection rate, the rate of cecal intubation and the bowel preparation. Th...
Eligibility Criteria
Inclusion
- Participants in the colorectal cancer screening program that give consent
Exclusion
- Contraindication for colonoscopy
Key Trial Info
Start Date :
December 6 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 20 2020
Estimated Enrollment :
858 Patients enrolled
Trial Details
Trial ID
NCT03763266
Start Date
December 6 2018
End Date
January 20 2020
Last Update
February 12 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Parc Taulí
Sabadell, Barcelona, Spain, 08208